on Nanohale AG (ETR:FYB)
Formycon AG Hosts Conference Call and Attends Investor Conferences
Formycon AG, a Germany-based biosimilar developer, is set to reveal its 2026 nine-month financial results on November 12. The company's management will discuss financial highlights and future plans during a live conference call. Interested parties are invited to register online to participate. The call is scheduled for 3:00 PM CET and will be conducted in English.
Additionally, Formycon will engage with investors at several international conferences. Key events include the Jefferies London Healthcare Conference and the Deutsche Börse Equity Forum in November. Further engagements are planned for early 2027, including participation in conferences in San Francisco and Hamburg.
These initiatives reflect Formycon’s commitment to transparency and its active role in fostering discussions with global investors. More details are available on the company’s website.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Nanohale AG news